Parvathy Venugopal
Adelaide Medical School
Faculty of Health and Medical Sciences
Dr. Parvathy Venugopal is a research fellow at the Centre for Cancer Biology in Adelaide, specialising in the genetics of inherited bone marrow failure syndromes and leukemia predisposition. With a strong foundation in regenerative medicine, she brings expertise in stem cell biology and disease modelling. Her work has significantly advanced the understanding of germline and somatic mutations driving inherited hematological disorders. She has been instrumental in the development of in vitro and in vivo models that are advancing knowledge of disease mechanisms in bone marrow failure and hematologic malignancies. Her research is driven by a strong interest in identifying the underlying genetic lesions that cause disease and in understanding the clonal dynamics of spontaneous somatic genetic rescue in inherited disease, offering potential clues to guide the development of novel therapeutic strategies.
A recipient of the prestigious Maddie Riewoldt’s Vision Fellowship (2020–23), Dr. Venugopal also plays key roles in the scientific community as a steering committee member for the National Symposium on Bone Marrow Failure Syndromes and as a biocurator for ClinGen’s Myeloid Malignancy Variant Curation Expert Panel since 2021.
-
Education
Date Institution name Country Title 2012 - 2016 University of Adelaide Australia PhD 2009 Manipal Institute of Regenerative Medicine India M.Sc Regenerative Medicine -
Research Interests
-
Journals
-
Conference Papers
Year Citation 2023 Scott, H. S., Zerella, J., Homan, C., Arts, P., Lin, S., Spinelli, S. J., . . . Hahn, C. N. (2023). ERG Is a New Predisposition Gene for Bone Marrow Failure and Hematological Malignancy. In BLOOD Vol. 144 (pp. LBA8). CA, San Diego: ELSEVIER.
DOI2022 Saygin, C., Roloff, G. W., Hahn, C. N., Chhetri, R., Gill, S., Elmariah, H., . . . Godley, L. A. (2022). Allogeneic Hematopoietic Stem Cell Transplant Outcomes in Adults with Inherited Myeloid Malignancies. In BLOOD Vol. 140 (pp. 10542-10544). LA, New Orleans: ELSEVIER.
DOI2022 Brown, A. L., Homan, C., Drazer, M. W., Yu, K., Lawrence, D., Feng, J., . . . Godley, L. A. (2022). Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in <i>RUNX1</i>, <i>GATA2</i> and <i>DDX41</i>. In BLOOD Vol. 140 (pp. 4030-4033). LA, New Orleans: AMER SOC HEMATOLOGY.
DOI2019 Venugopal, P., Babic, M., Barnett, C., Bray, S., Brown, A., Cheah, J., . . . Young, C. C. (2019). IMPLICATIONS OF REVERTANT SOMATIC MOSAICISM IN BONE MARROW FAILURE SYNDROMES. In EXPERIMENTAL HEMATOLOGY Vol. 76 (pp. S90). ELSEVIER SCIENCE INC.
DOI2019 Venugopal, P., Cheah, J. J. C., Eshraghi, L., Shahrin, N. H., Homan, C., Feng, J., . . . Scott, H. S. (2019). An Integrative Genomic Approach to Examine Mutations and Biological Pathways Associated with Hematological Malignancy Development in DDX41 Mutated Families. In BLOOD Vol. 134 (pp. 3 pages). Orlando, FL: AMER SOC HEMATOLOGY.
DOI WoS22019 Brown, A. L., Babic, M., Schreiber, A., Feng, J., Dobbins, J., Arts, P., . . . Scott, H. S. (2019). Familial Clustering of Hematological Malignancies: Harbingers of Wider Germline Cancer Susceptibility. In BLOOD Vol. 134 (pp. 3 pages). Orlando, FL: AMER SOC HEMATOLOGY.
DOI WoS12019 Hahn, C. N., Babic, M., Brautigan, P. J., Venugopal, P., Phillips, K., Dobbins, J., . . . Scott, H. S. (2019). Australian Familial Haematological Cancer Study - Findings from 15 Years of Aggregated Clinical, Genomic and Transcriptomic Data. In BLOOD Vol. 134 (pp. 4 pages). Orlando, FL: AMER SOC HEMATOLOGY.
DOI WoS22016 Bassal, M. A., Leo, P., Samaraweera, S. E., Maung, K. Z. Y., Babic, M., Venugopal, P., . . . D'Andrea, R. (2016). Metabolic Profiling of Adult Acute Myeloid Leukemia (AML). In BLOOD Vol. 128 (pp. 6 pages). San Diego, CA: AMER SOC HEMATOLOGY.
DOI WoS1
Connect With Me
External Profiles
